ALD and MLD to be Screened in Newborns in UK Generation Study
source: shutterstock.com

ALD and MLD to be Screened in Newborns in UK Generation Study

Patient Worthy partner Alex TLC has announced that, in a large-scale newborn screening study supported by the UK's NHS and Genomics England, adrenoleukodystrophy (ALD) and metachromatic leukodystrophy (MLD) will be…

Continue Reading ALD and MLD to be Screened in Newborns in UK Generation Study
Gene Therapy Saves Boy with ALD
source: pixabay.com

Gene Therapy Saves Boy with ALD

  Growing up, Priscilla Veneklause watched as her father struggled to manage his rare genetic disorder: adrenoleukodystrophy (ALD). Unfortunately, her father lost his fight with ALD when Priscilla was still…

Continue Reading Gene Therapy Saves Boy with ALD
Gene Therapy for Cerebral Adrenoleukodystrophy Earns FDA Accelerated Approval
source: shutterstock.com

Gene Therapy for Cerebral Adrenoleukodystrophy Earns FDA Accelerated Approval

According to a press release, the gene therapy company bluebird bio, inc. has recently announced that its gene therapy elivaldogene autotemcel (marketed as SKYSONA) has received Accelerated Approval status from…

Continue Reading Gene Therapy for Cerebral Adrenoleukodystrophy Earns FDA Accelerated Approval
FDA Halted Phase 3 Trial for Cerebral Adrenoleukodystrophy Due to Participant Developing MDS
source: pixabay.com

FDA Halted Phase 3 Trial for Cerebral Adrenoleukodystrophy Due to Participant Developing MDS

      Science Magazine recently joined other news sources in reporting that Bluebird Bio’s Phase 3 clinical trial investigating a treatment for a neurological disease was put on hold by…

Continue Reading FDA Halted Phase 3 Trial for Cerebral Adrenoleukodystrophy Due to Participant Developing MDS
New Trial Data Bodes Well for Experimental Cerebral Adrenoleukodystrophy Gene Therapy
skeeze / Pixabay

New Trial Data Bodes Well for Experimental Cerebral Adrenoleukodystrophy Gene Therapy

According to a story from pmlive.com, the gene therapy company Bluebird Bio's latest recently released results from the company's phase 2/3 clinical trial demonstrates further encouraging data for its Lenti-D…

Continue Reading New Trial Data Bodes Well for Experimental Cerebral Adrenoleukodystrophy Gene Therapy

Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women

According to a study published in the Orphanet Journal of Rare Diseases, a study that was intended to identify a new approach to monitoring the progression of x-linked adrenoleukodystrophy in women…

Continue Reading Study Reveals Slow Progression of X-Linked Adrenoleukodystrophy in Women
‘Mountain Man’ Maintains Work Out Regimen with ALD: A Wall Street Journal Profile 
Source: Pixabay.com

‘Mountain Man’ Maintains Work Out Regimen with ALD: A Wall Street Journal Profile 

Whose ready for some Monday motivation to get your week started? Readers of the Wall Street Journal might be familiar with their "What's Your Workout?" series, profiling someone's fitness and…

Continue Reading ‘Mountain Man’ Maintains Work Out Regimen with ALD: A Wall Street Journal Profile 
Treatment Development Getting Close for Patients with Form of Adrenoleukodystrophy
Source: Pixabay

Treatment Development Getting Close for Patients with Form of Adrenoleukodystrophy

Minoryx Therapeutics is on their way to making strides for patients with adrenomyeloneuropathy, also known as AMN, reports Labiotech. They just started their phase II initiative to test patients for…

Continue Reading Treatment Development Getting Close for Patients with Form of Adrenoleukodystrophy